CaMK2 alpha Polyclonal Antibody, Biotin Conjugated, Rabbit

Artikelnummer: BSS-BS-0771R-BIOTIN
Artikelname: CaMK2 alpha Polyclonal Antibody, Biotin Conjugated, Rabbit
Artikelnummer: BSS-BS-0771R-BIOTIN
Hersteller Artikelnummer: bs-0771R-Biotin
Alternativnummer: BSS-BS-0771R-BIOTIN-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IHC-Fr, IHC-P, WB
Spezies Reaktivität: Human, Mouse, Rat
Konjugation: Biotin
Alternative Synonym: CAMK2B, Calcium/calmodulin-dependent protein kinase type II subunit beta, CaM kinase II subunit beta, CaMK-II subunit beta, CAM2, CAMK2, CAMKB, CAMK, CAMK-II, CAMKG, CAMK2G, CAMK2A, CAMK2D, CAMKD
Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca2+/calmodulin-binding and autophosphorylation, and is involved in dendritic spine and synapse formation, neuronal plasticity and regulation of sarcoplasmic reticulum Ca2+ transport in skeletal muscle. In neurons, plays an essential structural role in the reorganization of the actin cytoskeleton during plasticity by binding and bundling actin filaments in a kinase-independent manner. This structural function is required for correct targeting of CaMK2A, which acts downstream of NMDAR to promote dendritic spine and synapse formation and maintain synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. In developing hippocampal neurons, promotes arborization of the dendritic tree and in mature neurons, promotes dendritic remodeling. Participates in the modulation of skeletal muscle function in response to exercise. In slow-twitch muscles, is involved in regulation of sarcoplasmic reticulum (SR) Ca2+ transport and in fast-twitch muscle participates in the control of Ca2+ release from the SR through phosphorylation of triadin, a ryanodine receptor-coupling factor, and phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 816
UniProt: Q13554
Puffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human CaMK2 alpha
Target-Kategorie: CaMK2 alpha
Application Verdünnung: WB(1:300-5000), IHC-P(1:200-400), IHC-F(1:100-500)